Browse contributions by subjects

Diseases

Brain Tumours
Breast Cancer
Paediatric Cancer
Prostate Cancer
Cancer in the Elderly
Cancer of Unknown Primary (CUP)
Colorectal Cancer
Gastric Cancer
Gynecological Cancer
Head & Neck Cancer
Lung Cancer
Malignant Lymphomas
Melanoma
Other Neoplasia
Rare Cancers

Treatments

Chemotherapy Agents Dev.
Methodology of Clinical Trials
Radiotherapy
Surgery
Bone Marrow Transplantation
Nuclear Medicine
Palliative and Supportive Care

Other

Imaging
Organisational Contributions
Cancer Epidemiology
Palaeo-Oncology
Translational Research Studies
Virus and Prevention

Most recent contributions

The story of hormonal therapy in breast cancer - and an important drug in oncology history, tamoxifen
A review entitled Past, present and future challenges in breast cancer treatment, published in 2014 to mark the 50th anniversary of the American Society of Clinical Oncology (ASCO), reported that anti-oestrogen treatments have had a “greater global impact than any other treatment intervention in cancer medicine”. The flagship in hormonal, or endocrine, therapy has been tamoxifen, one of the World Health Organisation’s essential drugs.
Read more
Publication date: 22/03/2023
International Society of Paediatric Oncology (SIOP) and SIOP Europe (SIOPE)
SIOP is the multidisciplinary society devoted to paediatric and adolescent cancers. It was founded in Europe and now has branches worldwide.
Read more
Publication date: 22/03/2023
Yes we scan: how MRI was trained on the prostate for detection and diagnosis
Finding out if there is cancer in the prostate and if it is clinically significant has been a major problem because it is hard to image the organ. But magnetic resonance imaging (MRI) has that capability – and the development of MRI technology and its applications including the prostate are European stories. However, proponents have had to battle resistance to its use by some urologists.
Read more
Publication date: 05/10/2022